Regulatory
CATH
Oct 2
— 0.00
Catheter Precision, Inc. amended its certificate of incorporation to change its corporate name to Flyte Aviation and authorized a one-for-10 reverse stock split effective October 5…
Regulatory
BLUO-U
Oct 2
— 0.00
Bluerock Acquisition Corp. II's fiscal year end 2026 financial statements were audited by WithumSmith+Brown and reported as fairly presented in conformity with GAAP.
Regulatory
STAR
Oct 2
— 0.00
Star Holdings, a Maryland statutory trust, amended its credit agreement with Safehold Inc. to permit voluntary prepayments and adjust interest rates, effective as of September 29, …
Regulatory
Federal
Oct 2
— 0.00
The Federal Reserve Board has issued an enforcement action against Ontario Bancorporation, Inc. This regulatory action impacts the mid-sized bank's operations.
Regulatory
BK9
Oct 2
— 0.00
A loan comprising 5.7% of the asset pool was confirmed, continuing a servicing and administration process tied to the trust agreement.
Regulatory
DBHL
Oct 2
▲ +0.66
Deep Isolation Nuclear announced the issuance of a drilling permit by the Texas Railroad Commission, a key milestone for its full-scale demonstration project using non-radioactive …
Regulatory
GIS
Oct 2
— 0.00
General Mills filed an Amended and Restated Certificate of Incorporation effective as of October 1, 2026, which updates the workforce and capital structure provisions of its charte…
Regulatory
IPSC
Oct 2
— 0.00
Century Therapeutics presented updated nonclinical data for its CNTY-813 islet therapy at EASD, demonstrating efficacy and supporting the planned IND submission for Q4 2026 and cli…
Regulatory
CNSY
Oct 2
— 0.00
The company filed an exhibit 99.1 containing a corporate presentation. The filing includes standard forward-looking statements regarding future operations, clinical trials, and pot…
Regulatory
CGEM
Oct 1
▲ +0.90
Cullinan announced an NDA submission for zipalertinib in combination with chemotherapy under the FDA Real-Time Oncology Review program based on Phase 3 clinical data, with mileston…
Regulatory
FDA
Oct 1
▲ +0.70
The U.S. FDA has approved the Autus Size-Adjustable Valve to treat pediatric patients with congenital pulmonary valve disease.
Regulatory
CURA · CURLF
Oct 1
▲ +0.70
Curaleaf Holdings was added to the FTSE Canada All Cap Index effective September 18, 2026, increasing liquidity and exposure to Canadian benchmark funds.
Regulatory
CTVA
Oct 1
— 0.00
PricewaterhouseCoopers consented to referencing their audit report for Combined Financial Statements included in the Form 8-K. This regulatory filing impacts the company's registra…
Regulatory
PWRU
Oct 1
— 0.00
Powerus Corporation filed amended articles to update its capitalization and governance structure via SEC Form 8-K. This regulatory filing is relevant to shareholders as it establis…
Regulatory
ABAT
Oct 1
▲ +0.90
American Battery Technology Company received U.S. government approval to export up to $100 million of recycled black mass, reinforcing its commercial leadership in domestic critica…
Regulatory
IBM
Oct 1
— 0.00
IBM filed updated bylaws as an exhibit to an October 8, 2026 form 8-K, amending the document approved in April 1958. The changes are effective as of October 1, 2026, with the resta…
Regulatory
BLUE
Oct 1
— 0.00
Blue Bird filed legal opinions regarding the resale of up to 2,702,180 shares of common stock as part of a registration statement on Form S-3ASR. The shares are issuable upon excha…
Regulatory
MSPR
Oct 1
▲ +0.50
Hazel Partners approved an additional $58,450 in funding, increasing the Operational Collection Escrow Floor to $8.7M as of September 2, 2026.
Regulatory
DPLS
Oct 1
— 0.00
DarkPulse inked an exclusive patent license agreement with the U.S. Department of the Air Force for six advanced technologies, advancing the company's space-based power grid develo…
Regulatory
BBCMS
Oct 1
— 0.00
The registrant has filed its Current Report on Form 8-K with the U.S. Securities and Exchange Commission, dated September 30, 2026.